معرفی
Professor Clara Chow is a distinguished academic and clinician serving as Academic Director of the Westmead Applied Research Centre (WARC) within the Faculty of Medicine and Health at the University of Sydney. She is a cardiologist and Clinical Lead of Community Based Cardiac Services at Westmead Hospital, while also holding a position on the Western Sydney Local Health District (WSLHD) Governing Board. Professor Chow directs the Australian Stroke and Heart Accelerator (ASHRA) and maintains an honorary appointment as Charles Perkins Centre Westmead Academic Co-director.
Professor Chow's research program focuses on cardiovascular disease prevention, innovative delivery of cardiovascular care, and evaluation of digital health interventions both in Australia and globally. She has expertise in clinical trial design and implementation, with particular interest in frugal innovation approaches. Her work spans from observational studies of cardiovascular disease determinants to clinical trials of simple interventions for prevention. She leads multiple studies in Australia and overseas, with an active program in e-health and m-health technologies for cardiovascular prevention. Her research extends to low-income countries, particularly India, and addresses management of high-risk cardiovascular disease populations.
Professor Chow has received numerous prestigious awards including being a finalist for the NSW Premier's Woman of the Year - Woman of Excellence Category in 2024 and 2020, a Research Australia Digital Health Technology Highly Commended Award, an Honour of Australia recipient, Fellow of the AAHMS (2023), and Telstra Brilliant Woman in Digital Health Award (2022). Her research output includes over 300 publications in leading medical journals including NEJM, JAMA, and Lancet, and she is supported by an NHMRC Investigator grant.
She supervises multiple higher degree research students and has been involved in significant clinical teaching. Professor Chow previously served as President of the Cardiac Society of Australia and New Zealand and continues to make substantial contributions to cardiovascular medicine through her research leadership, clinical practice, and policy development.
